Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
|Articles|October 2, 2015
- Pharmaceutical Technology-10-02-2015
- Volume 38
- Issue 10
Pharmaceutical Technology, October 2015 Issue (PDF)
Click the title above to open the Pharmaceutical Technology October 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
Identifying Powder Properties that Define Process Performancealmost 11 years ago
Connecting MES to Process Controlalmost 11 years ago
Parenteral Packaging Advancesalmost 11 years ago
Serialization Shake Outalmost 11 years ago
Investigating Biologicsalmost 11 years ago
Advances in Fluorination Chemistry for API Synthesisalmost 11 years ago
Small-Molecule API CMOs Are Thrivingalmost 11 years ago
Modular Platform for Agitator Bead Mill Optimizes Grindingalmost 11 years ago
Self-Contained Laboratory Homogenizer Prepares Injectable DrugsAdvertisement
Related to this article
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Tavapadon Sets Development Benchmark for Parkinson's
2
KRAS G12D Inhibitor's $2.13B Deal Tests Cross-Border Tech Transfer
3
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
4
PharmTech’s Weekly Roundup—September 25, 2026
5